Respiratory Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Regular Aspirin May Slow Emphysema Progression

Regular aspirin use is associated with a slower progression of early emphysema on computed tomography (CT) scans over the course of 10 years.

Breo Ellipta Inhaler Gains Expanded Indication

GlaxoSmithKline and Theravance announced that the Food and Drug Administration (FDA) has approved Breo Ellipta (fluticasone furoate/vilanterol) for the once-daily treatment of asthma in patients aged ≥18 years.

COPD and Sudden Cardiac Death Risk

Chronic obstructive pulmonary disease (COPD) is already the third leading cause of death in the world, and the condition might also raise a patient's odds for sudden cardiac death.

First Breath-Actuated, Dry-Powder Inhaler for Asthma

Teva announced that the FDA has approved ProAir RespiClick (albuterol sulfate inhalation powder), the first breath-actuated dry-powder inhaler approved for acute asthma symptoms.

No Connection Between Clean House, Asthma

Despite the widely accepted assumption that the rise in allergic disorders may be due to improved hygiene, a new study has found no connection between development of allergies and asthma and personal hygiene or home cleanliness.

For Acute LRTI: Azithromycin or Amoxicillin?

In a new review published in the Cochrane Library, researchers sought to compare the effectiveness of the macrolide antibiotic azithromycin to the broad-spectrum penicillin amoxicillin or amoxicillin/clavulanic acid (broad-spectrum penicillin + beta-lactamase inhibitor) for the treatment of lower respiratory tract infections.

E-Cigarettes Could Up Respiratory Infection Risk

Vapor from electronic cigarettes may increase young people's risk of respiratory infections, regardless of whether or not it contains nicotine.

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

News

Results Announced From Phase 3 Trial of Combo COPD Therapy

Novartis announced results from its Phase 3 EXPEDITION trial for indacaterol/glycopyrronium (QVA149) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD).

Soy Supplements May Not Help Uncontrolled Asthma After All

A new study published in JAMA has found that supplementation with soy isoflavone did not improve lung function or critical outcomes in patients with poor asthma control, despite previous research suggesting that it may be an effective treatment.

Inhaled Statins: The Future of Asthma Treatment?

Inhaled statins could become a novel class of inhaler therapy for airway diseases such as asthma, suggests a new study published in the journal Physiological Reports.

New Inhaler Option for COPD Now Approved

Boehringer Ingelheim announced that the Food and Drug Administration (FDA) has approved Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Featured courses from mycme

Asthma in the City: Rx Adherence BarriersExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Whooping Cough Epidemic Hit Vaccinated Kids HardExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Joint Pain a Major Issue in Chronic HCV InfectionExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters